- Project may not exceed 5 years;
- No $ limit

Standard NIH R01 application due dates apply: Feb 5, June 5, October 5.

PA-08-243 - Seeking applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed project must be on the basic biology, prevention, and/or treatment of liver cancer. Applications solely concerned with population studies and epidemiology will not be supported in connection with this FOA.

For information on eligibility, click HERE. 

For more information on this funding opportunity and how to apply, click HERE.